EMG
EW icon

Ellington Management Group’s Edwards Lifesciences EW Stock Holding History

Ellington Management Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-7,500
Closed -$364K – 556
2018
Q2 		$364K Buy
+7,500
New +$350K 0.03% 237
2014
Q4 		– Sell
-56,400
Closed -$960K – 577
2014
Q3 		$960K Buy
+56,400
New +$890K 0.66% 8
2013
Q4 		– Sell
-42,000
Closed -$487K – 623
2013
Q3 		$487K Buy
42,000
+12,000
+40% +$140K 0.09% 326
2013
Q2 		$336K Buy
+30,000
New +$355K 0.06% 467

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ellington Management Group's EW Position: Q3 2018 in Review

Ellington Management Group sold out of Edwards Lifesciences (EW) in Q3 2018, closing a stake of 7,500 shares — an estimated $364K sold.

Ellington Management Group first reported a position in EW in Q2 2013 and held it in 4 quarters. The position peaked at $960K in Q3 2014. 852 funds tracked by Wall St. Rank hold EW as of Q3 2018.

  • Ellington Management Group reported no remaining Edwards Lifesciences position as of Q3 2018 after selling out during the quarter.
  • Ellington Management Group sold 7,500 Edwards Lifesciences shares in Q3 2018, an estimated $364K.
  • Ellington Management Group first reported a position in Edwards Lifesciences in Q2 2013 and held it in 4 quarters.
  • Ellington Management Group's Edwards Lifesciences position peaked at $960K in Q3 2014.
  • 852 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2018.

Based on Ellington Management Group's 13F filing for Q3 2018, filed 14 Nov 2018.